Press and News

Read all about us!

  1. Dec 07

    Blood tests? Aisle 3: FDA greenlights BD & Babson’s fingertip collection system aimed at pharmacies, grocery stores

    Theranos had a lot of bad ideas, but making blood draws smaller and easier wasn’t necessarily one of them. A decade after the now-defunct blood-testing startup emerged from stealth, BD has now claimed an FDA clearance for fingerstick collection hardware that aims to bring the most common blood tests to pharmacies, grocery stores and other retail locations.

  2. Dec 07

    Babson Diagnostics’ BetterWay™ Blood Testing Service Achieves Critical Milestone Ahead of Commercialization

    Babson strategic partner BD (Becton, Dickinson and Company®) receives FDA 510(k) clearances for BD MiniDraw™ Capillary Blood Collection System. BD MiniDraw™ is a key component of Babson’s BetterWay™ blood testing, a first-of-its-kind offering that combines the convenience of capillary blood collection with the quality of laboratory testing

  3. Oct 13

    Trends Driving Innovation in Blood Sample Collection, Preparation

    Today’s clinical laboratory looks more and more like a manufacturing line and less and less like a scientist’s bench. However, the upstream processes of sample collection and preparation have remained largely unchanged over the same period, and in fact haven’t changed much for the past 70 years.

  4. Oct 01

    Theranos 2.0: The fingertip blood test that may actually work — this time

    David Stein tells a familiar story. His start-up has invented a device that, with blood from a single finger prick, can run dozens of blood tests and free millions of people from their terror of needles. The $50 billion medical diagnostics business, and, by extension, healthcare itself, is set to be revolutionised.

  5. Sep 12

    It's High Time to Normalize Pre-Visit Lab Testing

    In today’s rapidly changing health care landscape, clinicians are under increasing pressure to improve health outcomes and to enhance the patient experience. It’s a daunting challenge for medical practices in the face of endless administrative burdens and a growing shortage of health care workers. Patients today expect a modern experience that easily assimilates into their digital lives and meets their increasing focus on health and wellness. They are also notorious for skipping needed testing and not following up on care when it’s inconvenient.

  6. Aug 29

    Babson Diagnostics is making reimagined blood testing a reality

    Babson Diagnostics Inc. has line of sight for the commercial launch of its Betterway blood testing ecosystem, which is a less invasive way of taking blood and requires only one-tenth of the sample volume of venipuncture without sacrificing quality or accuracy.

  7. Aug 25

    Examining the blood collection experience

    Blood draws do not need to be unpleasant.

  8. Jun 02

    It's Time to Flip the Script on Blood Testing

    Babson CEO David Stein drops by the Let's Talk Medtech studio with an update on the company's progress to reimagine diagnostic blood testing.

  9. Apr 10

    Babson Diagnostics Welcomes New Clinical Advisor, Andrew Carroll, M.D.

    We're adding key clinical expertise as we move closer to commercialization of our next-generation blood testing ecosystem.

  10. Apr 07

    Meet the 2023 Austin Inno Madness champions

    Cue the music to Queen's classic "We Are The Champions" because we have a winner in the 2023 Austin Inno Madness bracket challenge. After battling through four rounds of voting, Babson Diagnostics has been named champion.

  11. Apr 04

    The Vibe at ViVE: A Progress Report on Healthcare Transformation

    The ViVE conference, powered by HLTH and CHIME, took place March 26-29 against the backdrop of new challenges for healthcare leaders. Nicholas Turos PharmD, vice president of business development with Babson Diagnostics, talks about how his company has reimagined the blood testing experience.

  12. Mar 28

    Babson Diagnostics and ClosedLoop Team Selected as 1st Place Winner of ‘Help with Hemolysis’ Data Analytics Challenge

    Competition co-hosted by Washington University and American Association for Clinical Chemistry challenges participants to solve real-world clinical laboratory challenges using data science.

  13. Mar 13

    Babson aims to shed Theranos curse with new blood testing tech

    Welcome to today’s Biotech Spotlight, a series featuring companies that are creating breakthrough technologies and products. Today, we’re looking at Babson Diagnostics, which is developing a novel blood testing process that requires drops, not vials, of blood.

  14. Mar 08

    Babson Diagnostics Celebrates International Women's Day

    Making meaningful progress to close the STEM Gap.

  15. Feb 02

    Babson Diagnostics Unveils Brand Identity for Next-Generation Blood Testing

    The new name of our diagnostic blood testing service is designed around the most important element of testing – the customer.

  16. Nov 21

    Validating Our Blood Testing Innovations

    What do we mean when we say we're a "science-first" company?

  17. Sep 20

    Babson Diagnostics Welcomes Four New Leaders to Management Team

    Key expertise added as Babson works to commercialize its reimagined blood testing ecosystem.

  18. Sep 07

    Preventative Healthcare Access for All Patients

    Better outcomes start with meeting patients where they are.

  19. Jul 26

    Babson Diagnostics and Pharmacy Podcast Network Announce Partnership That Will Take Listeners Inside Largest Retail Pharmacy Trade Show

    Media partnership announced in connection with the 2022 National Association of Chain Drug Stores' Total Store Expo.

  20. Jun 13

    Medical Claims Data Underscores Need to Improve Lab-Testing Access and Action

    Claims data underscores need to improve preventative care.

  21. Jun 07

    Why Innovation in Blood Testing Matters

    When people think about innovations that can reshape health care, why don’t they usually think about blood testing?

  22. May 11

    Babson Diagnostics, BD Expand Strategic Partnership to Advance Diagnostic Blood Collection in New Care Settings

    Expanded collaboration agreement to make less invasive blood sample collection more convenient and patient centered.

  23. Mar 21

    How Do We Fill The Data Gap In Virtual Care?

    Babson Diagnostics CEO David Stein details how can patients and providers get the most from virtual care.

  24. Mar 17

    Babson Diagnostics Recognized for Achieving Highest Standards for Laboratory Medicine

    Babson awarded accreditation by CAP for meeting the highest standards of quality and patient safety in lab practices.

  25. Jan 19

    Babson Diagnostics Grows Leadership Team with Key Executive Hires

    Healthtech firm prepares for commercial launch of disruptive blood-testing ecosystem.

  26. Jan 04

    Health Tech Needs to Rebuild Trust in the Wake of the Theranos Verdict

    Babson Diagnostics CEO David Stein shares some ideas about how we as an industry move forward from the Theranos scandal.

  27. Nov 12

    Raising Diabetes Awareness Starts with Testing

    With November being National Diabetes Month, it’s a good time to take stock of the toll this disease takes on our country.

  28. Oct 15

    Pharmacies and the Future of Health Care

    Use of COVID-19 testing and vaccination services at community pharmacies demonstrates they can play a bigger role in care delivery.

  29. Jul 27

    Babson Diagnostics Strengthens Senior Leadership Team with Two Appointments

    Babson brings in top talent from the largest and most respected retail and health care services organizations in the country.

  30. Jun 29

    Babson Diagnostics Raises $31 Million in Series B Funding to Drive Retailization of Customer-First, Convenient, and Highly Accessible Diagnostic Blood Testing

    The Series B fundraise will accelerate the commercialization of Babson’s disruptive technology that will make routine blood testing easier, more accessible, and less invasive.

  31. May 04

    Time for Innovation in Blood Testing Technology

    We live in a just-in-time world. We only need to pick up our smartphones and within moments we order a car to drive us home. Or book a reservation at a hotel or restaurant.

  32. Mar 09

    Babson Diagnostics Named Fierce MedTech "Fierce 15" Company

    Babson named one of Fierce Medtech’s elite “Fierce 15" as a promising private company in the global health care industry.

  33. Jan 25

    Babson Diagnostics First to Conduct Full Blood Panel Testing from a Finger Sample in a Retail Setting

    According to the CDC, 70% of today’s medical decisions depend on laboratory test results, and over 14 billion laboratory tests are ordered annually—but primary care clinicians indicate up to 30% of prescribed diagnostic tests are not filled by patients.

  34. Sep 24

    Babson Diagnostics Closes $13.7 Million Series A to Democratize Diagnostic Blood Testing

    Babson announced today it closed $13.7 million in cumulative Series A funding, led by Siemens Healthineers, Prism Ventures, Genesis Merchant Capital, and Lago Consulting Group.

  35. Sep 24

    Babson Diagnostics Appoints Former Siemens Healthineers Executive to CEO

    Babson has appointed David Stein, Ph.D., former head of global strategy and innovation at Siemens Healthineers, to chief executive officer. Eric Olson, Babson’s founder and former CEO, will assume the roles of chairman of the board and chief operating officer.

  36. Jun 25

    Babson Diagnostics Receives FDA Emergency Use Authorization for its SARS-CoV-2 IgG Antibody Test

    Babson announced today that its SARS-CoV-2 IgG antibody test, Babson Diagnostics aC19G1, has received emergency use authorization (EUA) from the Food and Drug Administration (FDA).

  37. May 20

    Babson Diagnostics Enters Collaborative Research Agreement with Dell Medical School to Study Immune Response to COVID-19

    Babson announced today it has entered into a collaborative research agreement with Dell Medical School at The University of Texas at Austin (Dell Med) to study the immune response to COVID-19.

  38. Apr 30

    Babson Diagnostics Launches COVID-19 Serology Test for IgG Antibodies with 100% Specificity in Austin

    Babson announces launch of its first COVID-19 serology test to detect IgG antibodies to SARS-CoV-2 in the bloodstream through a select network of retail and clinical partners in Austin, Texas.

  39. Apr 15

    Babson Diagnostics to Offer High-Throughput COVID-19 Serology Testing in Austin, Texas

    Babson announces it will launch a COVID-19 serology testing service to detect the presence of antibodies to SARS-CoV-2 in the bloodstream.

  40. Mar 11

    Babson Diagnostics Bolsters Board of Directors with Three Diagnostics Industry Experts

    Babson announces that it has expanded its board of directors to include diagnostics industry leaders David Stein (Director), Dennis Gilbert (Director), and Dave Hickey (Observer).

  41. Feb 12

    BD, Babson Diagnostics Announce Strategic Partnership Agreement to Enable Small-Volume Blood Collection for Diagnostic Testing in Retail Settings

    BD and Babson Diagnostics announce a long-term strategic partnership agreement to bring laboratory-quality, small-volume blood collection to retail pharmacies.

  42. Jul 30

    Babson Diagnostics announces its Scientific Advisory Board

    Babson has established its Scientific Advisory Board. Drs. Alan Wu, Susan A. Evans, and Robert H. Christenson will join the Babson team as scientific advisors.

  43. May 23

    Babson Diagnostics Wins Austin A-List Award

    Babson named a winner at the Greater Austin Chamber of Commerce’s 2019 Austin A-List Awards, “Austin’s premiere honor for homegrown companies.”

  44. May 14

    Babson Diagnostics welcomes Mini Kahlon to its Board of Directors

    Babson welcomes Mini Kahlon as the newest member of its Board of Directors.

  45. Mar 11

    Babson Diagnostics featured in Capital City Innovation Annual Report

    Babson featured in Capital City Innovation's 2018 Annual Review. Capital City Innovation is a 501(c)(3) nonprofit focused on cultivating collaboration and growth in Austin's Innovation District.

  46. Oct 19

    Babson Diagnostics secures $3.5 million in Series A financing from Prism Ventures

    Babson secures $3.5 million in Series A financing on October 4 from Prism Ventures, a New York-based advisory and investment firm specializing in life sciences.

Media contact

For PR and media inquiries, please reach out to